摘要
目的 探讨CT灌注成像(CTP)对 非小细胞肺癌(NSCLC)放疗疗效的评估价 值。方法 收集经病理证实并行放疗治疗 NSCLC患者90例,分别于放疗前后行CTP检 查,获取肿瘤区CTP参数血容量(BV)、血 流量(BF);比较NSCLC放疗前后BV、BF变 化,并应用ROC曲线分析BV值降低率、BF 值降低率对NSCLC放疗疗效的评价效能。 结果 90例患者,放疗治疗后,CR 0例, PR 46例,SD 37例,PD 7例,缓解率为 51.11%(46/90);NSCLC放疗后BV、BF值较 放疗前均明显降低(P<0.05)。与非缓解组 相比,放疗后缓解组BV值降低率、BF值降 低率均明显增大(P<0.05)。ROC曲线分析 显示,以BV值降低率=43.20%、BF降低值 率=16.50%为截断值评价NSCLC放疗缓解的 效能最佳,ROC曲线面积分别为0.839、 0.811,相应敏感度、特异度、准确度分 别为82.61%、88.64%、85.56%和80.43%、 84.09%、82.22%。结论 CTP参数BV、BF 值降低率可作为NSCLC放疗疗效的评价指 标。
Objective To explore the value of CT perfusion imaging (CTP) in evaluating the curative effect of radiotherapy for non-small cell lung cancer (NSCLC). Methods Ninety-six patients with pathologically confirmed NSCLC who underwent radiotherapy were selected. CTP was performed before and after radiotherapy to obtain CTP parameters blood volume (BV) and blood flow (BF) in the tumor area. The changes of BV and BF before and after radiotherapy were compared. The ROC curve was used to analyze the efficiencies of the reduction rate of BV and the reduction rate of BF for evaluation of the curative effect of radiotherapy. Results Among the 90 patients, there was no patient with CR, 46 patients with PR, 37 patients with SD and 7 patients with PD after radiotherapy, and the remission rate was 51.11% (46/90). The BV and BF were significantly decreased after radiotherapy (P<0.05). Compared with the non-remission group, the reduction rates of BV and BF were significantly higher in the remission group after radiotherapy (P<0.05). ROC curve analysis showed that the efficiencies of reduction rates of BV and BF (43.20% and 16.50%) were the best for evaluation of the curative effect of radiotherapy. The areas under ROC curve were 0.839 and 0.811. The corresponding sensitivities, specificities and accuracy rates were 82.61%, 88.64%, 85.56% and 80.43%, 84.09% and 82.22%, respectively. Conclusion CTP parameters, namely the reduction rates of BV and BF can be used as evaluation indexes for the curative effect of radiotherapy for NSCLC.
【关键词】非小细胞肺癌;放射治疗;CT 灌注成像;疗效评价
【中图分类号】R734.2
【文献标识码】A
【DOI】 10.3969/j.issn.1672- 5131.2019.03.012
前言
肺癌是全球致死率最高的恶性肿瘤,其中非小细胞肺癌(non small cell lung cancer,NSCLC)占80%[1]。其起病隐匿,多数患者发 现时已属于晚期,放化疗成为主要治疗手段。近年来,随着放化疗技 术的的成熟,其疗效取得显著提高。早期准确预估NSCLC治疗反应, 以利于及时调整治疗方案,对改善患者预后有着重要意义[2]。影像学 检查是评估NSCLC放化疗疗效的主要手段,临床常采取RECIST标准,根 据治疗前后肿瘤直径大小变化来评估治疗治疗反应,但形态学评估方 法并不能定量反映抗血管生成效果,用于早期疗效评价存在一定局限 性。CT灌注成像(CT perfusion,CTP)是一种新兴的功能成像技术,其 能够获取肿瘤微血管信息,并以血容量(blood volume,BV)、血流量 (blood flow,BF)等多项灌注参数进行定量。CTP在肺肿瘤性质鉴别、 病理分型中有着广泛应用[3]。而其对肺癌疗效评价作用亦是当前临床 研究热点,并已取得初步成果[4]。本研究采用CTP技术测量NSCLC放疗 前后BV、BF参数,旨在探讨它们应用于NSCLC放疗疗效评价中的临床价 值,以期为临床个体化治疗提供指导,现报告如下。
中国CT和MRI杂志
第17卷, 第 3 期
2019年03月
相关文章